Loading company…
Rarity Bioscience develops technology to detect small amounts of DNA sequence variants.
Rarity Bioscience's superRCA technology detects single-variant mutations. Its applications include monitoring measurable residual disease and analyzing DNA in liquid biopsies and clinical trials. Founded in 2021, the company is based in Uppsala, Sweden. It raised EUR 6.5 million in venture funding led by Navigare Ventures in June 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in